16:00 EDT Celcuity (CELC) trading halted, news pending
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CELC:
- Celcuity initiated with an Outperform at Citizens
- Celcuity’s Earnings Call: Big Data, Bigger Ambitions
- Celcuity Buy Rating Backed by Strong Gedatolisib Data, Upcoming VIKTORIA-1 Catalyst, and Favorable Risk-Reward
- Celcuity price target raised to $141 from $108 at Craig-Hallum
- Celcuity: Clinical Momentum, Strong Balance Sheet, and Regulatory Catalysts Underpin Buy Rating and $122 Target